Comparative performance of COVID-19 serology testing

BACKGROUND: The 2019 novel coronavirus infectious disease (COVID-19) pandemic resulted in a surge of assays aimed at detecting severe acute respiratory syndrome (SARS) – coronavirus (CoV) – 2 infection and prior exposure. Although both molecular and antigen testing have clearly defined uses, the uti...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Nam K., May, Larissa, Cohen, Stuart H., Rodrigo, John, Gong, Raymond, Liu, Ying, Conner, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259022/
https://www.ncbi.nlm.nih.gov/pubmed/35818626
http://dx.doi.org/10.1016/j.plabm.2022.e00289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259022/
https://www.ncbi.nlm.nih.gov/pubmed/35818626
http://dx.doi.org/10.1016/j.plabm.2022.e00289

Ejemplares similares